RANTES Produced by Actiated Lymphocytes Costimulated by Anti-CD3 mAb and Anti-CD28 mAb

被引:0
|
作者
Gu, Xiao [1 ]
Tang, Xiao-Da [1 ]
Gu, Shen-Yang [2 ]
Yang, Shang-Qi [1 ]
Zhou, Pei-Jun [1 ]
Xu, Da [3 ]
Wang, Xiang-Hui [3 ]
Tan, Jian-Ming [1 ]
机构
[1] Clin. O. Transplant. Ctr. Shanghai, Shanghai First People's Hospital, Shanghai 200080, China
[2] Department of Urology, Clinical Medical College, Yangzhou University, Yangzhou 225001, China
[3] Department of Urology, Affil. Hosp. S. Med. Univ. Shanghai, Shanghai 200025, China
来源
Fudan University Journal of Medical Sciences | 2003年 / 30卷 / 06期
关键词
Cells - Patient monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose: To investigate the changes of regulated upon activation, normal T cell expressed and secreted (RANTES) level produced by activated lymphocytes costimulated by CD28 pathway and the effects of Cyclosporin A(CsA). Methods: Human peripheral lymphocytes separated by Ficoll were divided into four groups: anti-CD3mAb group, anti-CD28mAb group, CD28 costimulation group and control group. CD28 costimulation group was treated by different concentrations of PDTC or CsA. RANTES levels were detected by ELISA and CD25 and CCR5 expression of lymphocytes were detected by FCM. Results: RANTES concentration was significantly higher in CD28 costimulation group than other group (P < 0.05). RANTES secreted by lymphocytes could be inhibited by PDTC or CsA. CD25 expression was upregulated after lymphocytes costimulated by CD28 pathway, on the contrary, CCR5 was significantly downregulated (P < 0.05). Conclusions: CD28 costimulating lymphocytes play a important role on RANTES generation which regulated by NF-κB pathway. Lymphocytes producing RANTES and their reaction to RANTES were both related to CD28 pathway. Inhibiting the secretion of RANTES may be one of the important immunosuppressive mechanisms of CsA.
引用
收藏
页码:546 / 548
相关论文
共 50 条
  • [41] Effects of exopolysaccharides from Cyanobacterium aponinum from the Blue Lagoon in Iceland on anti-CD3/anti-CD28 stimulated T cells
    Gudmundsdottir, Asa B.
    Brynjolfsdottir, Asa
    Olafsdottir, Elin S.
    Hardardottir, Ingibjorg
    Freysdottir, Jona
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2016, 83 (05) : 357 - 357
  • [42] Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: Implications for cell therapy in a murine model
    Ito, F
    Carr, A
    Svensson, H
    Yu, JY
    Chang, AE
    Li, Q
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (03): : 222 - 233
  • [43] Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies
    Harada, M
    Okamoto, T
    Omoto, K
    Tamada, K
    Takenoyama, M
    Hirashima, C
    Ito, O
    Kimura, G
    Nomoto, K
    IMMUNOLOGY, 1996, 87 (03) : 447 - 453
  • [44] Immobilized anti-CD3 mAb induces anergy in murine naive and memory CD4(+) T cells in vitro
    Chai, JG
    Lechler, RI
    INTERNATIONAL IMMUNOLOGY, 1997, 9 (07) : 935 - 944
  • [45] Immunological Biomarker for Overall Immunosuppression (IS) in Liver Transplant (LTx) Recipients Using Proliferation Index of CD4 & CD8 Lymphocytes Stimulated With Monoclonal Anti-CD3 & Anti-CD28 Antibodies
    Mukerji, A.
    Potula, R.
    Geier, S.
    Parekh, H.
    Karachristos, A.
    Maloo, M.
    Jain, A.
    LIVER TRANSPLANTATION, 2014, 20 : S309 - S310
  • [46] Combined cytoreduction and infusion of anti-CD3/anti-CD28 bead-activated T cells prevent diabetes in NOD mice.
    Berenson, RJ
    Long, SA
    Bonyhadi, ML
    BLOOD, 2005, 106 (11) : 850A - 850A
  • [47] STIMULATION OF PERIPHERAL-BLOOD T-CELLS WITH ANTI-CD3 AND ANTI-CD28 RESULTS IN A SUSTAINED INCREASE IN EXTRACELLULAR ACIDIFICATION RATE
    WADA, HG
    FOK, K
    PITCHFORD, S
    FASEB JOURNAL, 1994, 8 (05): : A782 - A782
  • [48] THE USE OF ANTI-CD3 AND ANTI-CD28 MONOCLONAL-ANTIBODIES TO CLONE AND EXPAND HUMAN ANTIGEN-SPECIFIC T-CELLS
    RIDDELL, SR
    GREENBERG, PD
    JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 128 (02) : 189 - 201
  • [49] Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and anti-CD28 antibodies
    Kalamasz, D
    Long, SA
    Taniguchi, R
    Buckner, JH
    Berenson, RJ
    Bonyhadi, M
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (05) : 405 - 418
  • [50] Preservation of murine T cell alloreactivity following ex vivo activation with anti-CD3 and anti-CD28 antibody coated beads.
    Rettig, MP
    DiPersio, JF
    Ritchey, JK
    Nervi, B
    Bonyhadi, ML
    BLOOD, 2003, 102 (11) : 746A - 746A